Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
15.12.2016 22:55:00

Global - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast

NEW YORK, Dec. 15, 2016 /PRNewswire/ -- Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity. The primary growth factors for the SMBG market is the increasing global diabetic population; increasing awareness among the diabetes population, increasing spending on healthcare, active reimbursement policies and the technological advancement aimed at minimal and non-invasive testing methods.

Key Highlights

- United States, Russia and United Kingdom are the top three leading countries in the Global SMBG market.

- China is at the fourth spot being closely followed by Italy with XX percent market share of the Global SMBG market.

- China dominates the self-monitoring of blood glucose users, with XX percent users share in 2015.

- Test Strips account for maximum share of the SMBG market.

- Blood glucose test strips market is mainly dominated by developed countries.

- Blood glucose meter is the second leading product segment while lancet captures the least share of the SMBG market.

- In 2014, Life Scan became the leading player in SMBG market.

This is the 2nd edition report on Blood Glucose Device Market by iGATE RESEARCH. The report titled "Global - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast" is a 309 Page report with 305 Figures and 16 Tables. This report analyses the Country Wise Diabetes Population, Country Wise SMBG Users and Market, Company Wise SMBG Revenue and the driving factors and challenges for the SMBG market.


The SMBG Market covered in the report is analyzed from 4 viewpoints follows:

1. Country Wise Diabetes Population and Forecast (2007 - 2021)
I. Type 1 Diabetes Population
II. Type 2 Diabetes Population
2. Country Wise SMBG Users and Forecast (2007 - 2021)
3. Country Wise SMBG Market and Forecast (2007 - 2021)
I. Blood Glucose Test Strips Market
II. Blood Glucose Lancet Market
III. Blood Glucose Meter Market
4. Company Wise SMBG Revenue and Forecast (2007 - 2021)

The 18 Countries analyzed in the reports are as follows:

1. United States
2. Brazil
3. United Kingdom
4. Germany
5. Spain
6. Italy
7. Netherlands
8. Norway
9. Sweden
10. Switzerland
11. Russia
12. India
13. China
14. Thailand
15. Korea
16. Malaysia
17. Australia
18. Kuwait

The 4 Companies analyzed in the reports are as follows:

1. Roche Diagnostic
2. LifeScan Inc
3. Bayer HealthCare
4. Abbott Laboratories

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Read the full report: http://www.reportlinker.com/p04128997-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global---self-monitoring-of-blood-glucose-smbg-test-strips-lancet-meter-market-and-forecast-300379446.html

SOURCE Reportlinker

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!